[1]
2025. Immunological and Clinical Aspects Determining the Risk of Recurrence in Patients with Luminal Subtype of Breast Cancer Stages I–III. Voprosy onkologii. 71, 3 (Jun. 2025), OF-2271. DOI:https://doi.org/10.37469/0507-3758-2025-71-3-OF-2271.